Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    GC P#02.01.001
Show Display Options
Rank Status Study
1 Completed Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy
Conditions: Hematologic Malignancies;   Acute Myeloid Leukemia;   Lymphoid Leukemia;   Chronic Myeloid Leukemia;   Hodgkin's Disease;   Non-Hodgkin's Lymphoma;   Myelodysplastic Syndromes
Intervention: Drug: StemEx®

Study has passed its completion date and status has not been verified in more than two years.